Michael brings over a decade of experience spanning finance, program management, and research having supported both private and public biotechnology companies across all phases of drug development from drug discovery to commercial launch preparation. Most recently, serving as Senior Director, FP&A at Sierra Oncology, he led all financial planning and analysis activities across the company. Earlier at Sierra, he held roles in Program Management and Research contributing to a successful IND submission, and preclinical and clinical development for multiple pipeline assets. Michael earned an MBA from the Ross School of Business at the University of Michigan and a BA in History from the University of Michigan.